non-small cell lung cancer
Conditions
Interventions
None listed
Sponsors
Matsusaka Municipal Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (i) Patients whose FFPE led to a diagnosis of non-small cell lung cancer (ii) Necrotic component >20% after macrodissection (iii) Blood tests can be collected before treatment (iv) Age at the time of obtaining consent must be 20 years or older (v) Written consent to participate in this study has been obtained from the patient.
Exclusion criteria
Exclusion criteria: (i) Cases where it is deemed difficult to submit ODxTT and AmoyDx with FFPE specimens, and Compact Panel Dx with FFPE or cytology specimens due to sample volume, or where the aforementioned multi-gene tests make it difficult to submit other tests considered necessary in routine clinical practice. (ii) Cases in which the tumor cell percentage is less than 30% even if macrodissection is performed. (iii) Other cases deemed unsuitable by the physician in charge.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Success rate of analysis using ODxTT and AmoyDx with FFPE specimens and Compact Panel Dx with FFPE or cytology specimens. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of success rates between ODxTT and Compact Panel Dx; comparison of success rates between ODxTT and AmoyDx; driver gene detection rates by analysis using ODxTT and AmoyDx in FFPE specimens and Compact Panel Dx using FFPE or cytology specimens. | — |
Countries
Japan
Contacts
Public ContactTadashi Sakaguchi
Matsusaka Municipal Hospital Department of Respiratory Medicine
Outcome results
None listed